Trial Profile
Evaluation of the clinical performance of the Medtronic Endeavor ABT-578 eluting coronary stent system in patients undrgoing primary PCI for acute myocardial infarction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2014
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Sponsors Medtronic
- 30 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 30 Mar 2010 New trial record